Health & Science
- Medical Research
106 articles
Sort
Page 1 of 5
per page
Trump and RFK Jr. Boosted This Unproven Autism Drug. Some Parents Listened
Ed Cara, Gizmodo.com
The FDA recently declined to endorse leucovorin for autism, citing a lack of strong evidence for it.
May 18, 2026, 3:13 PM
WATCH: How a new drug could lengthen lives of pancreatic cancer patients
ABC News, Abcnews.com
ABC News’ Linsey Davis explains the numbers behind a new pancreatic cancer treatment that almost doubles the prognosis for patients, and speaks to Dr. Brandon Huffman, whose team is behind the drug.
May 15, 2026, 3:32 AM
These families help researchers find Alzheimer's treatments. Their network is at risk
Jon Hamilton, NPR
Families with rare gene mutations that cause Alzheimer's in middle age are giving scientists a unique window on the disease, and a quick way to test potential treatments.
May 7, 2026, 1:32 PM
Does a psychedelic trip change your brain? A new study offers a tantalizing clue
Jackie Flynn Mogensen, Scientific American
Scientists gave people a “heroic” dose of psilocybin and then looked at their brain. Here’s what happened
May 5, 2026, 3:45 PM
Why the FDA rejected a ‘breakthrough’ melanoma drug
K. R. Callaway, Scientific American
The FDA rejected the promising skin cancer drug RP1 twice, leaving many puzzled and worried about what this means for other drug approvals
May 2, 2026, 3:20 PM
Trump, ibogaine and the science behind the psychedelics boom in the U.S.
Rachel Feltman, Sushmita Pathak, Alex Sugiura, Scientific American
Tracing how psychedelics have undergone a revival in the U.S. and what the White House’s new psychedelic push means for research
May 1, 2026, 10:00 AM
RFK, Jr., puts psychedelics on fast track to FDA review and approval
Claire Cameron, Scientific American
The U.S. Food and Drug Administration is seeking to accelerate the review process for three companies that are studying psilocybin and an MDMA-like drug as treatments for depression and PTSD
Apr 24, 2026, 4:50 PM
Monkeys walk around a virtual world using only their thoughts
New Scientist
Monkeys with around 300 electrodes implanted in their brain were able to steer avatars around different virtual environments
Apr 15, 2026, 6:00 PM
A synthetic angiotensin II/ACE2-based hormone shunt controlling experimental hypertension
Gokberk Unal, Maysam Mansouri, Yu-Qing Xie, Christian Mueller, Ghislaine Charpin-El Hamri, Martin Fussenegger, Nature.com
Chronic diseases require lifelong maintenance. Here, the authors present ARCH, a closed-loop genetic circuit that autonomously maintains Angiotensin-II homeostasis, demonstrating translational potential against RAS-dependent hypertension.
Apr 11, 2026, 12:00 AM
How do mRNA vaccines work, and why are they safe and effective?
Meghan Bartels, Scientific American
The COVID pandemic ushered mRNA vaccines into the spotlight, and the technology has even greater potential. Here’s what to know about the way that they work, their safety, and more
Mar 27, 2026, 11:00 AM
NIH pivots away from agency-directed science
Max Kozlov, Nature.com
US biomedical funding behemoth says the approach will boost innovation, but some researchers worry that understudied areas of science will suffer.
Mar 17, 2026, 12:00 AM
As parents clamor for a treatment touted for autism, doctors hesitate to prescribe it
Michal Ruprecht, NPR
After the leucovorin got public attention as a potential autism treatment, families rushed to get it. Many doctors are torn about prescribing an unproven drug but don't want to lose patients' trust.
Mar 16, 2026, 9:00 AM
RFK Jr. Tells Joe Rogan He’s About to Unleash 14 Banned Peptides
Ed Cara, Gizmodo.com
RFK Jr. plans to reverse a sweeping compounding ban of certain peptides issued by the FDA in late 2023.
Mar 2, 2026, 8:30 PM
FDA agrees to review Moderna mRNA flu vaccine in dramatic reversal
Claire Cameron, Scientific American
After initially rejecting Moderna’s application for review, the FDA will now consider the company’s mRNA flu shot
Feb 18, 2026, 2:50 PM
Could DMT Be a New Treatment for Depression? A Small Study Says Yes
Ed Cara, Gizmodo.com
People taking DMT tended to experience significant relief from their depression for up to three months, the researchers found.
Feb 16, 2026, 4:05 PM
What drugs are safe during pregnancy? There’s a shocking lack of data
Giorgia Guglielmi, Nature.com
Drug trials have typically excluded pregnant people for safety reasons. But that’s now starting to change.
Feb 11, 2026, 12:00 AM
Top medical groups join forces to review vaccine science as CDC faces criticism
Claire Cameron, Scientific American
The American Medical Association is launching an effort to evaluate vaccine safety and effectiveness independently of U.S. government health agencies
Feb 10, 2026, 9:20 PM
What RFK Jr.’s Unproven Autism Treatment Could Mean for Autistic Patients and Their Families
Ed Cara, Gizmodo.com
RFK Jr. has stated leucovorin will help "large numbers of children who suffer from autism." Many experts are skeptical about that.
Feb 7, 2026, 12:00 PM
Elon Musk says it's 'highly likely' humans figure out how to reverse aging — but there's 'some benefit to death'
Lauren Edmonds, Business Insider
During the World Economic Forum on Thursday, Elon Musk said there's a reason human's don't have longer lifespans.
Jan 22, 2026, 6:26 PM
Exclusive: key NIH review panels due to lose all members by the end of 2026
Max Kozlov, Nature.com
Thirteen of the agency’s advisory councils, which must review grant applications before funding is awarded, are on track to have no voting members.
Jan 22, 2026, 12:00 AM
NIH Agrees to Evaluate Stalled Scientific Grants
Dan Vergano, Scientific American
Health officials have agreed to assess pending medical research grants after a Trump administration antidiversity purge put them on ice
Dec 30, 2025, 6:00 PM
Akebia Therapeutics Expands Portfolio Beyond Anemia with New Rare Kidney Disease Pipeline Centered on AKB-097 and Praliciguat
Maham Fatima, Yahoo Entertainment
Akebia Therapeutics Inc. (NASDAQ:AKBA) is one of the cheap penny stocks to invest in. On December 1, Akebia Therapeutics announced the official establishment...
Dec 28, 2025, 5:46 PM
After NIH grant cuts, breast cancer research at Harvard slowed, and lab workers left
Martha Bebinger, NPR
Amid NIH funding delays, reversals and uncertainty, a scientist at Harvard who studies breast cancer has lost one-third of her lab employees and wonders if she can continue her research experiments.
Dec 9, 2025, 10:00 AM
BMY Gains Attention as Bayer Reports FXIa Trial Success
Vardah Gill, Yahoo Entertainment
Bristol-Myers Squibb Company (NYSE:BMY) is included among the 15 Best Boring Dividend Stocks to Buy. Bayer reported positive Phase 3 results for its FXIa ...
Nov 30, 2025, 7:27 PM